My prediction of the first Catalyst is acceptance of mTNBC BTD followed by good Nash results that will also be filed as a BTD and accepted in the first quarter. The Brazil Covid trials will also fill and seek EUA with hopefully great results that are heard world wide.
When we voted for the 200 million authorized shares for this year the hope was that the first quarter would see a rise in stock price as these indications showed promise and great results which would start our accent in stock price.
Nader said that we would see more value in the 200 million shares as the price went up and that it would give us bargaining strength with a possible partner. Nader also said something very important if you listened closely. If we don’t receive a proper or good offer to partner for whatever is our first partnership that we don’t have to accept a insufficient offer because of our strength in shares.
What this meant to me is if we do not receive a good offer for just one and not all of our indications because we do not want a partner for all our indications. This much is clear. The difficulty will be keeping a partner to just one indication and a good offer to partner for that one indication. We have the 200 million shares that would of had a value increase by this time with a BTD accepted for mTNBC, another filing for BTD for brain metastasis, Nash results with a following filing of BTD, a possible Critical Covid results that could bring a EUA internationally and filing of our BLA for Duel HIV all in the first quarter. The opportunities this provides for us all should not be overlooked.
The values increase in the 200 million shares will be much more and the strength it gives us could be 5-20 times its current value or even more. With potential like this and say something in the middle like $10/share price with all these catalysts happening all close together. The value could be as much as 2 billion dollars. This is what Nader was trying to deliver without putting a number on the value like I just did. If we have this kind of value it allows us the opportunity to not take any measly low ball offer to partner and gives us much more control of our destiny. We will not accept a low ball offer with a billion or more dollars in stock value. We will be able to afford to go our own way and finance our company into a massive growth in growing into our own big pharmaceutical company. This is what Nader and Scott have said on a few occasions. We should have the ability to go either direction. Partner or not to partner. This is our strength for having authorized the 200 million shares.
I hoped that the strength and the timeline would all happen in the first quarter of 2022. This all still looks possible to me. My choice has always to see our stock value increase exponentially to $5-20 dollars a share and build ourselves into a future mammoth pharmaceutical company. The real deal is to grow by ourselves and the highest return on our investment is to grow alone. With a billion or two billion dollars or what could be much more… who needs a partner to steal half of our profits?
In any case going forward. Authorizing the 200 million stock shares allowed us the power to pick our own path. Either… a one indication partnership or go it alone. This was a wise move by Nader and Scott to put us in this position and shows they look to our future for shareholders value. I really look forward to the next few months as it will define who we are and who we will become. Let’s hope the shortsightedness of a buy-out does not raise its ugly head. Because that is the worst case scenario a CYDY shareholder could see. I would never vote for a buy-out and accept pennies on the dollar for our potential to see some other big Pharma steal our potential and our chance of becoming a bigger pharmaceutical company. Hell… maybe in a few years from now we buy out Merck or Gilead? With 90+ indications and a huge amount of block Buster potential indications… this could be entirely possible. Don’t underestimate our future potential… the stars are aligning in my opinion. How we as shareholders end up voting when the time comes… will set our direction and our future. My vision is we go it alone and become the biggest pharmaceutical company… wouldn’t that be the ultimate? This is my 2 cents of an opinion. Take it for what it is worth. It won’t buy you a cup of coffee but it makes for nice dreams… my dreams sometime come true in my world. Let’s hope this is one of them that becomes true!
When we voted for the 200 million authorized shares for this year the hope was that the first quarter would see a rise in stock price as these indications showed promise and great results which would start our accent in stock price.
Nader said that we would see more value in the 200 million shares as the price went up and that it would give us bargaining strength with a possible partner. Nader also said something very important if you listened closely. If we don’t receive a proper or good offer to partner for whatever is our first partnership that we don’t have to accept a insufficient offer because of our strength in shares.
What this meant to me is if we do not receive a good offer for just one and not all of our indications because we do not want a partner for all our indications. This much is clear. The difficulty will be keeping a partner to just one indication and a good offer to partner for that one indication. We have the 200 million shares that would of had a value increase by this time with a BTD accepted for mTNBC, another filing for BTD for brain metastasis, Nash results with a following filing of BTD, a possible Critical Covid results that could bring a EUA internationally and filing of our BLA for Duel HIV all in the first quarter. The opportunities this provides for us all should not be overlooked.
The values increase in the 200 million shares will be much more and the strength it gives us could be 5-20 times its current value or even more. With potential like this and say something in the middle like $10/share price with all these catalysts happening all close together. The value could be as much as 2 billion dollars. This is what Nader was trying to deliver without putting a number on the value like I just did. If we have this kind of value it allows us the opportunity to not take any measly low ball offer to partner and gives us much more control of our destiny. We will not accept a low ball offer with a billion or more dollars in stock value. We will be able to afford to go our own way and finance our company into a massive growth in growing into our own big pharmaceutical company. This is what Nader and Scott have said on a few occasions. We should have the ability to go either direction. Partner or not to partner. This is our strength for having authorized the 200 million shares.
I hoped that the strength and the timeline would all happen in the first quarter of 2022. This all still looks possible to me. My choice has always to see our stock value increase exponentially to $5-20 dollars a share and build ourselves into a future mammoth pharmaceutical company. The real deal is to grow by ourselves and the highest return on our investment is to grow alone. With a billion or two billion dollars or what could be much more… who needs a partner to steal half of our profits?
In any case going forward. Authorizing the 200 million stock shares allowed us the power to pick our own path. Either… a one indication partnership or go it alone. This was a wise move by Nader and Scott to put us in this position and shows they look to our future for shareholders value. I really look forward to the next few months as it will define who we are and who we will become. Let’s hope the shortsightedness of a buy-out does not raise its ugly head. Because that is the worst case scenario a CYDY shareholder could see. I would never vote for a buy-out and accept pennies on the dollar for our potential to see some other big Pharma steal our potential and our chance of becoming a bigger pharmaceutical company. Hell… maybe in a few years from now we buy out Merck or Gilead? With 90+ indications and a huge amount of block Buster potential indications… this could be entirely possible. Don’t underestimate our future potential… the stars are aligning in my opinion. How we as shareholders end up voting when the time comes… will set our direction and our future. My vision is we go it alone and become the biggest pharmaceutical company… wouldn’t that be the ultimate? This is my 2 cents of an opinion. Take it for what it is worth. It won’t buy you a cup of coffee but it makes for nice dreams… my dreams sometime come true in my world. Let’s hope this is one of them that becomes true!
14
1
